Taiwan Medical Device Registration

Unlock the Taiwanese market with expert regulatory guidance, quality system oversight, and an independent Taiwan agent, with Cisema.

We help foreign manufacturers of Taiwan medical devices and IVDs in Taiwan successfully register their products with the Taiwan Food and Drug Administration (TFDA), meet all documentation and quality system documentation requirements, and maintain compliance across the device lifecycle. As your Taiwan Registration Holder (TRH), we manage your Taiwan medical device registration process from initial classification strategy through post-market surveillance.

With a presence in Taipei and a deep understanding of Taiwan’s Medical Devices Act, Cisema acts as your trusted in country regulatory representative. We provide complete support for device classification, technical reviews, quality system documentation QSD, and registration submission for Class I, Class II, and III devices.

Whether registering a new product, seeking amendments to your medical device permit license, or managing post-market obligations, Cisema gives you clarity, speed, and control.

From risk assessment and QMS alignment to TFDA application support and labeling compliance, we simplify your path to market. We also assist with documentation aligned to the Good Manufacturing Practice requirements and ISO 13485, ensuring conformity with Taiwan medical device expectations.

Taiwan Medical Device Registration
Medical Device Registration in Taiwan

IVD & Medical Device Registration in Taiwan Services

Cisema’s team manages your full medical device registration in Taiwan, aligning with the Taiwan Food and Drug Administration authority’s requirements and supporting a seamless market entry.

Regulatory Strategy & Classification

Classify your Taiwan medical device or IVD under Taiwan’s risk-based framework (Class I, Class II, or Class III)
Determine whether fast-track or pre market approval based on reference countries is applicable
Define the most effective regulatory pathway according to your primary intended actions

Quality System Documentation (QSD) Registration

Before submitting your product registration application to TFDA, most manufacturers must obtain a Quality System Documentation (QSD) certificate. This mandatory step verifies your compliance with ISO 13485 or an equivalent quality management system. We guide you in preparing and submitting your full QSD application and managing all interactions with TFDA until your certificate is issued.

QSD is required for all Class II and III devices, and many Class I products
Some Class I non-sterile, non-measuring devices may be exempt
QSD approval is performed as a remote, paper-based review by the Taiwan Food and Drug authority
Documentation includes ISO 13485 certificate, SOPs, quality manual and facility details
QSD and product registration can be submitted in parallel, but TFDA will issue the medical device permit license only after QSD approval
Typical QSD review time is around 6 months and the certificate is valid for 3 years.

Registration Application & TFDA Submission

Submit through the TFDA e-Portal and manage all administrative and technical reviews
Act as your regulatory contact for communication with the TFDA
Localize Instructions for Use (IFU), packaging, and labeling to meet Taiwan Food and Drug Administration standards
Coordinate submission fees and respond to authority feedback throughout the pre market approval process.

Post-Approval Services

Handle renewals, reclassification, and amendments to the medical device permit license
Manage adverse event reporting, serious adverse event follow-up, and Field Safety Corrective Actions (FSCA) coordination.

Taiwan Agent & Taiwan Registration Holder Services

Foreign manufacturers must appoint a Taiwan agent or in country regulatory representative as the legal license holder to register with the Taiwan Food and Drug Administration. Cisema acts as your compliant TRH, fulfilling all regulatory duties transparently.

What we do:

Serve as your legal license holder for all Taiwan medical device, IVD and combined product registrations
Submit and maintain your product license with TFDA
Issue Letters of Authorization to your preferred importers and distributors
Enable flexibility in changing distributors without re-registration
Monitor post-market updates and ensure compliance with the Medical Devices Act
Manage direct prevention actions like FSCA and recalls
Maintain your quality system, and support audits and inspections tied to ISO 13485

Medical Device Post-Market Surveillance & Vigilance Services

Cisema supports Taiwan Registration Holders with medical device post-market surveillance, safety reporting, corrective actions, and ongoing regulatory compliance.

Safety Surveillance & Reporting

Support serious adverse event reporting to TFDA within 15 days of discovery
Support investigations and corrective and preventive measures
Maintain required records for at least five years
Support safety surveillance plans and periodic safety reports

Corrective Action & Recall Support

Support immediate notification and corrective measures where required
Support alerts, testing, suspension of use, and medical device recalls
Manage recalls according to applicable classifications and deadlines

Distribution & Vigilance Records

Maintain required supply-source and distribution records
Maintain relevant post-market surveillance and regulatory records
Support ongoing traceability and compliance

Licence Renewal & Annual Declarations

Support medical device licence renewal before expiry
Submit Class I annual reports and notify TFDA of Class II/III QSD updates
Support ongoing Taiwan Registration Holder obligations

Quality Control Inspection Services in Taiwan

Cisema also provides tailored inspection services for Taiwan medical devices and IVDs to ensure compliance with local and international standards.

Incoming Goods Inspections

Verify packaging, labeling, and shipping conditions upon arrival
Review documentation including invoices, certifications, and declarations of conformity
Confirm product readiness for the Taiwanese market

In-Process Quality Monitoring

Inspect during repackaging or relabeling for hygiene, SOPs, and quality system control
Validate traceability and batch consistency

Final Product Release Inspections

Conduct AQL sampling and performance checks
Ensure conformity of labeling and IFU with Taiwanese regulatory requirements

Special Inspection Projects

Support Good Manufacturing Practice audits and TFDA site inspections
Collaborate with third-party bodies for tailored compliance audits
Conduct serial number validation and corrective action reviews.

Why Work with Cisema?

Local expertise with global reach

Our bilingual teams bridge international quality standards with local regulations

Proven track record

Over 20 years supporting market approvals and compliance in China and Asia Pacific

End-to-end solutions

From system setup to post-market surveillance, we ensure quality management and regulatory compliance throughout the product lifecycle

Industry breadth

Cross-sector expertise in life sciences, food, veterinary, consumer and industrial goods

Role of a China Agent

Useful Articles

View More

China Medical Device GMP vs ISO 13485: Key Differences Explained

Understand the key differences between China Medical Device GMP and ISO 13485, including requirements for quality management, suppliers, facilities and documentation.

October 15, 2026
China Medical Device GMP vs ISO 13485: Key Differences Explained
Two Chinese medical device technicians, a woman and a man wearing white lab coats, surgical caps, face masks, and protective gloves, stand side by side in a sterile cleanroom environment.

What Is China’s UDI System & How Does It Affect Medical Device Registration?

Learn about China's Unique Device Identification (UDI) system and how to navigate China’s evolving medical device market.

October 12, 2026
What Is China’s UDI System & How Does It Affect Medical Device Registration?

How Does GBA Real World Data Support China NMPA Approvals?

Discover how leveraging Real World Data generated in the Greater Bay Area can accelerate market entry for medical products in China.

October 12, 2026
How Does GBA Real World Data Support China NMPA Approvals?

Guide to Indonesia Medical Device Post-Registration Changes: Notification, Variation, or New Registration

Learn when medical device and IVD changes in Indonesia require a notification, variation, or new registration, and how to maintain ongoing regulatory compliance.

October 12, 2026
Guide to Indonesia Medical Device Post-Registration Changes: Notification, Variation, or New Registration

How Singapore Accelerates ASEAN Market Entry for Medical Devices, Pharma, & Cosmetics

This guide explains Singapore’s HSA regulatory system and why it is a strategic first step for entering Southeast Asian markets with medical devices, pharmaceuticals, and cosmetics.

October 12, 2026
How Singapore Accelerates ASEAN Market Entry for Medical Devices, Pharma, & Cosmetics

China Medical Device Approval Tracker: Imported Class II & III Devices

Track all imported Class II and III medical device approvals in China with this monthly updated NMPA submission tracker.

September 29, 2026
China Medical Device Approval Tracker: Imported Class II & III Devices
Previous
Previous

Other Markets We Support for Medical Device & IVD Registration

In addition to Taiwan, Cisema supports IVD and device registration, regulatory representation, and quality inspection services in:

China

Hong Kong SAR

Singapore

Malaysia

Vietnam

Philippines

Indonesia

Thailand

South Korea

Read the Latest Regulatory News

View More

Hong Kong Requires MDACS Listing for Injectable Dermal Fillers by March 1, 2027

New requirements could affect how injectable devices, including dermal fillers, are supplied in Hong Kong’s private healthcare sector.

September 29, 2026
Hong Kong Requires MDACS Listing for Injectable Dermal Fillers by March 1, 2027

China Enacts First Healthcare Security Law: Impact on Global Medtech

China’s new Healthcare Security Law affects medical device reimbursement, health economic evidence, payment models, and digital traceability from 2027.

September 25, 2026
China Enacts First Healthcare Security Law: Impact on Global Medtech

Indonesia Mandates Pre-Shipment Halal Verification for Imported Products

BPJPH Regulation No. 4 of 2026 introduces pre-shipment halal verification and LPPH reports for imported goods starting September 2026.

September 25, 2026
Indonesia Mandates Pre-Shipment Halal Verification for Imported Products

NMPA Issues World’s First Industry Standard for Medical Devices Using/Adopting BCI Technology

China’s NMPA has released YY/T 2029–2026, establishing the world's first AI-BCI EEG dataset quality standard for medical devices ahead of its September 2027 enforcement.

September 23, 2026
NMPA Issues World’s First Industry Standard for Medical Devices Using/Adopting BCI Technology

China Issues First Ethical Guidelines for Artificial Intelligence Medical Imaging Research

China’s Science Ministry issued ethical guidelines establishing strict standards for AI medical imaging data, algorithm validation, and ethics reviews.

September 15, 2026
China Issues First Ethical Guidelines for Artificial Intelligence Medical Imaging Research

TFDA Simplifies Paperwork for Medical Device Applications in Taiwan

From October 1, 2026, TFDA will expand electronic review and stop issuing paper copies of approved labeling for Class I, II, and III medical devices in Taiwan.

September 11, 2026
TFDA Simplifies Paperwork for Medical Device Applications in Taiwan
Previous
Previous

Cisema's Taiwan Office

Cisema (Taipei) Limited / 凱思瑪台北有限公司

7th Floor, No. 2-1 Wenhu Street
Neihu District, Taipei City 11445
Taiwan

Contact Us

Get in Touch with Our Medical Devices Team

And discover how we can support you in achieving approval for your medical device in Taiwan.

Request Proposal